Tommy Fibich, a Houston Personal Injury lawyer

Position: Founding Partner

Speak with tommy


“My fights are won or lost far away from witnesses—behind the lines, in the gym or on the road long before I dance under the lights”. – Muhammad Ali

“Lawsuits require the same dedication to preparation and I will not
be outworked. It’s just that simple.”

– Tommy Fibich

Tommy Fibich is a widely respected Texas Trial Attorney who has dedicated 45 years to a life of law and advocacy. Over the course of his career, Tommy has helped a diverse clientele prevail in high-stakes and complex claims ranging from serious personal injury to product liability, commercial torts, and fraud.

Reputation for Success

Through an approach centered on ample preparation and driven by an unceasing work ethic, Tommy has secured numerous victories against some of the largest corporate defendants in the world and has secured millions of dollars in compensation on behalf of clients. His reputation among the local and legal communities as a passionate fighter and fearless litigator have been shaped by his years of consistent success, as well as his many noteworthy verdicts and settlements.

Leader in the Legal Field

Board Certified in Civil Trial Law by the Texas Board of Legal Specialization, Tommy has been recognized as the University of Houston Law Center’s Alumnus of the Year (2004), elected to the American Board of Trial Advocates, and named to the prestigious Texas Super Lawyers list every year since 2003. In 2019, he was named by the Texas Bar Foundation as the recipient of the Ronald D. Secrest Outstanding Trial Lawyer award.

Award-Winning Legal Representation

Attorney Fibich’s professional awards are just one measure of his esteemed reputation among legal peers.

These hallmarks of excellence include:

  • University of Houston Law School 2004 Alumnus of the Year
  • Member of Multi-million Dollar Advocates Forum®
  • Selected for inclusion in Thomson Reuters Super Lawyers® Magazine
    from 2003-2018
  • Nominated by the Texas Association of Civil Trial Specialists for Lifetime
    Achievement in the practice of law
  • Elected to the American Board of Trial Advocates
  • Board Certified by the Texas Board of Legal Specialization in Civil Trial Law
  • Designated by his peers to the highest standard of professionalism in
    the profession – preeminent recognition in legal ability and ethical standards
    for 25 consecutive years by Martindale-Hubbell®.

Providing Trustworthy Legal Counsel

Tommy is proud to have been raised in a humble but honest home in Bruni, Texas. He attended High School in San Antonio and graduated from the University of Texas in Austin. Followingservice in the United States Army, he entered the University of Houston law school, where he graduated in 1974 as a member of the Order of Barons, the highest scholastic honorary society.

Tommy is cognizant of the fact that he represents people who have little chance of obtaining justice without the Fibich legal team. “I have to say that the diversity of experiences I had in growing up and my relationships with people of all walks of life have afforded me a great background for picking the right jurors in jury selection as well as communicating with them in trial.” While today he is a leader in his profession, Tommy Fibich never forgets where he came from.

Tommy Fibich Has Gone Up Against Large Companies

Tommy Fibich was recently in trial against Abbott Laboratories, Inc. in federal court in St. Louis, Missouri. Tommy Fibich was lead trial counsel in the drug product liability case which alleged that Abbott’s drug Depakote was ingested during pregnancy and ultimately caused severe birth defects to the child.* This was the first Depakote birth defect case to go to trial, and there are approximately 850 Depakote cases pending across the country.

Abbott Laboratories previously pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of Depakote for uses not approved as safe and effective by the Food and Drug Administration, according to the U.S. Justice Department.**

* D.W.K., a minor by Mary Kaleta and Daniel Kaleta, individually as parents and next friends of D.W.K. v. Abbott Laboratories, Inc., no. 14-cv-847-NJR-SCW, United States District Court, Southern District of Illinois, East St. Louis Division. ** -label-promotion-depakote, published May 7, 2012.


University of Houston Law Center, Houston, Texas

  • J.D., 1974
  • Honors: Member, Order of the Barons
  • Honors: Honorary Legal Scholastic Society

BAR Admissions

  • Texas, 1974
  • U.S. District Court Southern District of Texas, 1976
  • U.S. Court of Appeals 5th Circuit, 1976
  • U.S. Supreme Court, 1978
  • U.S. Tax Court, 1986

Professional Associations

  • American Board of Trial Advocates
  • Board Certified in Civil Trial Law by the Texas Board of Legal Specialization
  • Texas Super Lawyer by Thomson Reuters ® – 2003-2018

Areas Of Practice

  • Pharmaceutical Drug Litigation
  • Nursing Home Litigation
  • Product Liability

Recent Publications

  • The Future of Civil Litigation: Counterpoint, After Wyeth Why Section 82.007, in Light of Wyeth v. Levine,
  • Prevents Texans from Holding Drugmakers to FDA Standards, by Tommy Fibich and Joe Melugin, Texas Bar Journal, May 2009
  • In the wake of the U.S. Supreme Court decision Wyeth v. Levine, a misguided Texas statute faces a new challenge.

© 2020 All Rights Reserved.